Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FX46N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,678
Award facts
- Contract value 100% obligated
- $5,677.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 15, 2025, for the supply of Gemtesa 75 mg tablets in a quantity of 90 units. The contract is a firm fixed price delivery order with a ceiling value of $5,677.67 and an ultimate completion date of September 16, 2025. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical supplier to the federal government's medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio encompasses a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Gemtesa, a medication used in urology and urogynecology, exemplifies the company's role in fulfilling federal medical supply requirements through the DLA's comprehensive pharmaceutical support vehicle.
Quick answers
Who was awarded contract SPE2DB25FX46N?
SPE2DB25FX46N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FX46N worth?
The government has obligated $5,678 on SPE2DB25FX46N.
Is contract SPE2DB25FX46N an order under another contract?
Yes. SPE2DB25FX46N is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX46N competed?
The extent of competition for SPE2DB25FX46N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award